CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 106 enrolled
Drug / intervention
Placebo Administration +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04620369
NCT04620369Phase 3Completed

Rose Geranium in Sesame Oil Nasal Spray as an Agent to Improve Symptoms of Nasal Vestibulitis: A Phase III Double Blinded Randomized Controlled Trial

Mayo Clinic·interventional·Posted Nov 9, 2020·Updated Dec 3, 2025

In Brief

A Phase 3 clinical trial evaluating Placebo Administration, Questionnaire Administration, and 1 other intervention for Hematopoietic and Lymphoid Cell Neoplasm and 2 related conditions. Completed, enrolled 106 participants across 20 sites.

Detailed Summary

This phase III trial compares rose geranium in sesame oil nasal spray to isotonic nasal saline in improving symptoms of nasal vestibulitis in cancer patients receiving chemotherapy. Nasal (nose) symptoms (dryness, discomfort, bleeding, scabbing or sores) due to inflammation, termed nasal vestibulitis, is reported as a side effect of cancer-directed therapy. Rose geranium in sesame oil nasal spray may work better than isotonic nasal saline in improving symptoms of nasal vestibulitis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 3CompletedFinished
202120222023202420252026
First PostedNov 9, 2020
Enrollment StartNov 13, 2020
Primary CompletionDec 15, 2022
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 5.6 years ago

Interventions

Placebo Administrationdrug

Instill isotonic nasal saline intranasally

Questionnaire Administrationother

Ancillary studies

Rose Geranium in Sesame Oil Nasal Spraydrug

Instill intranasally